Effects of intramyocardial injection of phVEGF-A165 as sole therapy in patients with refractory coronary artery disease--12-month follow-up: angiogenic gene therapy.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples